Search

Golnaz Morad

from Houston, TX
Age ~38
Get Report
Connected to:
Alexis M Morad, 46Anik M Morad, 72Armen Morad, 43Bassam Morad, 55Chaman Morad, 87Elbadrawy Morad, 62Elhafed Morad, 42Justin Morad, 38Ratson Morad, 67Rene M Morad, 39

Golnaz Morad Phones & Addresses

  • Houston, TX
  • Jamaica Plain, MA
  • Cambridge, MA

Work

Company: Md anderson cancer center Mar 2020 Position: Postdoctoral research fellow

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Harvard University 2013 to 2019 Specialities: Biology, Philosophy

Skills

Cancer Biology • Extracellular Matrix • Extracellular Vesicles • Exosomes • Metastasis • Dentistry • Stem Cells

Languages

English • French • Spanish

Industries

Medical Practice

Resumes

Resumes

Golnaz Morad Photo 1

Postdoctoral Research Fellow

View page
Location:
Houston, TX
Industry:
Medical Practice
Work:
Md Anderson Cancer Center
Postdoctoral Research Fellow
Harvard University
Graduate Student
Dental Research Center Shahid Beheshti University of Medical Science 2011 - Apr 2013
Research Fellow
Private Practice 2011 - Apr 2013
Dentist
Education:
Harvard University 2013 - 2019
Doctorates, Doctor of Philosophy, Biology, Philosophy Shahid Beheshti University of Medical Sciences 2004 - 2010
Doctorates, Doctor of Dental Surgery, Dentistry
Skills:
Cancer Biology
Extracellular Matrix
Extracellular Vesicles
Exosomes
Metastasis
Dentistry
Stem Cells
Languages:
English
French
Spanish

Publications

Us Patents

Use Of Rab7 Gtpase (Rab7) Inhibitors In Enhancing Permeability Of The Blood Brain Barrier (Bbb)

View page
US Patent:
20220275371, Sep 1, 2022
Filed:
Apr 23, 2020
Appl. No.:
17/605799
Inventors:
- Boston MA, US
Golnaz Morad - Boston MA, US
Assignee:
Children's Medical Center Corporation - Boston MA
International Classification:
C12N 15/113
A61K 9/127
A61K 45/06
A61P 35/00
C12Q 1/6886
Abstract:
Provided herein are compositions and methods for delivery an agent (e.g., diagnostic agent or therapeutic agent) to the brain using an extracellular vesicle comprising the agent and a Rab7 inhibitor. Methods of diagnosing or treating a brain disease are also provided.

Platform For Assessment Of The Transcytosis Of Extracellular Vesicles Across Endothelial Barriers And Uses Thereof

View page
US Patent:
20210041421, Feb 11, 2021
Filed:
Mar 14, 2019
Appl. No.:
16/979710
Inventors:
- Boston MA, US
Golnaz Morad - Boston MA, US
Assignee:
Children's Medical Center Corporation - Boston MA
International Classification:
G01N 33/50
G01N 33/574
A61K 31/4709
A61K 31/517
Abstract:
Provided herein are methods of determining whether an extracellular vesicle (EV) can cross an endothelial barrier (e.g., the blood brain barrier). In some embodiments, the EV originates from a cancer cell. In some embodiments, the cancer has a higher likelihood of metastasizing (to the brain) if the EV originating from a cancer cell is determined to be able to cross an endothelial barrier (e.g., the blood brain barrier). Thus, further provided herein are methods of determining whether a subject who has cancer is likely to develop metastatic cancer. In some embodiments, the subject is treated for the metastatic cancer accordingly.
Control profile
Golnaz Morad from Houston, TX, age ~38 Get Report